» Articles » PMID: 34237796

Pharmacological Properties, Therapeutic Potential, and Legal Status of Cannabis Sativa L.: An Overview

Overview
Journal Phytother Res
Publisher Wiley
Date 2021 Jul 8
PMID 34237796
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Marijuana, or Cannabis sativa L., is a common psychoactive plant used for both recreational and medicinal purposes. In many countries, cannabis-based medicines have been legalized under certain conditions because of their immense prospects in medicinal applications. With a comprehensive insight into the prospects and challenges associated with the pharmacological use and global trade of C. sativa, this mini-review focuses on the medicinal importance of the plant and its legal status worldwide; the pharmacological compounds and its therapeutic potential along with the underlying public health concerns and future perspective are herein discussed. The existence of major compounds including Δ -tetrahydrocannabinol (Δ -THC), cannabidiol, cannabinol, and cannabichromene contributes to the medicinal effects of the cannabis plant. These compounds are also involved in the treatment of various types of cancer, epilepsy, and Parkinson's disease displaying several mechanisms of action. Cannabis sativa is a plant with significant pharmacological potential. However, several aspects of the plant need an in-depth understanding of the drug mechanism and its interaction with other drugs. Only after addressing these health concerns, legalization of cannabis could be utilized to its full potential as a future medicine.

Citing Articles

Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis.

Predescu I, Jijie A, Patrascu D, Pasc A, Piros E, Trandafirescu C Pharmacy (Basel). 2025; 13(1).

PMID: 39998006 PMC: 11859396. DOI: 10.3390/pharmacy13010007.


Treatment Strategies for Painful Pelvic Floor Conditions: A Focus on the Potential Benefits of Cannabidiol.

Bonanni R, Ratano P, Cariati I, Tancredi V, Cifelli P Biomolecules. 2025; 14(12.

PMID: 39766334 PMC: 11727302. DOI: 10.3390/biom14121627.


A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors.

Miao Y, Zhao F, Guan W Int J Neuropsychopharmacol. 2024; 28(2).

PMID: 39657242 PMC: 11878560. DOI: 10.1093/ijnp/pyae064.


Nanocarriers for Cannabinoid Delivery: Enhancing Therapeutic Potential.

Singh V, Vihal S, Rana R, Rathore C Recent Adv Drug Deliv Formul. 2024; 18(4):247-261.

PMID: 39356097 DOI: 10.2174/0126673878300347240718100814.


The Role of Cannabis in the Development of Psychosis.

Turkoglu O, Ertugrul A Turk Psikiyatri Derg. 2024; 35(3):234-244.

PMID: 39224996 PMC: 11375744. DOI: 10.5080/u27122.